Search results for "Venous thromboembolism"


 
Results 31 - 40 of about 338 for "Venous thromboembolism".
Sort by: Relevance | Newest | Oldest

For inpatient VTE prevention, rivaroxaban noninferior to enoxaparin

Rivaroxaban is noninferior to enoxaparin for standard-duration venous thromboembolism (VTE) prophylaxis in acutely ill patients, a new study found.
https://acphospitalist.acponline.org/weekly/archives/2013/02/13/3.htm
13 Feb 2013

Cases from St. Joseph Mercy Ann Arbor

Amyloid cardiomyopathy, Haemophilus influenzae infection, metastatic melanoma and more.
https://acphospitalist.acponline.org/archives/2017/09/brief-case-st-joseph-mercy-ann-arbor.htm
15 Sep 2017

Recent Research

Thrombolytic therapy and acute PE, bleeding risk in patients on warfarin before MI, and more.
https://acphospitalist.acponline.org/archives/2012/07/rr.htm
15 Jul 2012

May 2007

ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2007/05/

Intermittent pneumatic compression helps reduce VTE risk

Intermittent pneumatic compression (IPC) to the lower limbs can reduce venous thromboembolism (VTE) risk in hospitalized patients and is especially effective when combined with pharmacologic thromboprophylaxis, a new meta-analysis found.
https://acphospitalist.acponline.org/weekly/archives/2013/07/24/1.htm
24 Jul 2013

Infection, other factors may increase risk for VTE hospitalization

Infection, treatment with erythropoiesis-stimulating agents, and blood transfusion may increase risk for hospitalization due to venous thromboembolism (VTE), according to a new study.
https://acphospitalist.acponline.org/weekly/archives/2012/04/11/2.htm
11 Apr 2012

Longer venous thromboprophylaxis after total hip replacement decreases events, ups minor bleeding risk

Venous thromboprophylaxis for 21 days or more after total hip replacement lowers risk for venous thromboembolism, pulmonary embolism and deep venous thrombosis while increasing the risk for minor bleeding, according to a new study.
https://acphospitalist.acponline.org/weekly/archives/2012/03/21/3.htm
21 Mar 2012

Risk score helps determine 30-day mortality in patients with cancer and PE

A simple risk score may help determine 30-day mortality risk in patients with active cancer and acute pulmonary embolism (PE), a new study has found.
https://acphospitalist.acponline.org/weekly/archives/2012/08/01/4.htm
1 Aug 2012

UFH, LMWH similar in cost, efficacy for VTE prophylaxis

Unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) have similar costs and effectiveness for venous thromboembolism (VTE) prophylaxis, but LMWH is associated with fewer complications, a new study found.
https://acphospitalist.acponline.org/weekly/archives/2012/04/11/3.htm
11 Apr 2012

NIH guidelines on anticoagulation in COVID-19; research on statin use, omicron variant

The NIH updated its guidelines to address anticoagulation in COVID-19 inpatients, treatment with atorvastatin did not appear to improve outcomes in the ICU, and several studies looked at characteristics of omicron.
https://acphospitalist.acponline.org/archives/2022/01/12/free/nih-guidelines-on-anticoagulation-research-on-statins-and-COVID-19.htm
12 Jan 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next